Auropharma is a good fundamental company and is in watchlist because Rakesh Jhunjhunwala is invested in it. Its having pressure due to its exposure to the US market. Most of the brokerage houses are maintaining the target as 850.
FNO Analysis -
The FNO analysis suggests huge put volume rise on 590 PE. It has a huge support at 520 and 530 levels and resistance at 540 and 560 levels.
Stop loss on a closing basis has to be maintained very strictly because of the current bearish sentiment in the market. The risk and reward of this trade are pretty lucrative.